M.G. Finn said that since vaccines are given to healthy people, researchers need way more trial volunteers than with other types of drugs. "Getting the people to actually participate in the test is often the most difficult thing ... There's a lot of vaccines being developed for the same condition, obviously, and so having a central place where volunteers can go, I think, makes a lot of sense."